Table 2: Concordance of IgG titer results obtained by CTT (1+ strength as end point) with pre-DTT and post DTT treatment results obtained by CAT (1+/2+/3+ strength as end point).
|
IgG |
|||
|
pCAT (1+) |
|
|
|
|
Anti-A |
28.7 (560) |
14 (274) |
57.3 (1119) |
|
Anti-B |
17.5 (344) |
8 (157) |
74.5 (1461) |
|
pCAT (2+) |
|
|
|
|
Anti-A |
21.3 (427) |
49.6 (995) |
29.1 (583) |
|
Anti-B |
30.9 (617) |
33.1 (661) |
35.9 (717) |
|
pCAT (3+) |
|
|
|
|
Anti-A |
11.5 (225) |
82.7 (1613) |
5.7 (112) |
|
Anti-B |
10.9 (215) |
84 (1659) |
5.2 (102) |
|
CAT (1+) |
|
|
|
|
Anti-A |
6.4 (128) |
0.6 (12) |
93 (1865) |
|
Anti-B |
3.5 (71) |
0 (0) |
96.5 (1934) |
|
CAT (2+) |
|
|
|
|
Anti-A |
40.3 (806) |
12.3 (254) |
47.4 (948) |
|
Anti-B |
32 (641) |
6.5 (131) |
61.5 (1233) |
|
CAT (3+) |
|
|
|
|
Anti-A |
19.9 (396) |
74.4 (1472) |
6 (119) |
|
Anti-B |
23.8 (477) |
66.1 (1352) |
10.1 (203) |
CAT: Pre DTT treatment; pCAT: Post DTT treatment.